Gossamer Bio, Inc. (GOSS) SEC Filings — 2024

Filings

• Gossamer Bio, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Gossamer Bio, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Gossamer Bio Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
• Gossamer Bio Faces Nasdaq Delisting Notice — 8-K · Sep 13, 2024
• Gossamer Bio Reports Flat Q2 Revenue — 10-Q · Aug 12, 2024
• Gossamer Bio, Inc. SC 13G/A Filing — SC 13G/A · Aug 2, 2024
• Gossamer Bio to be Acquired by Cerberus for $1.2B — 8-K · Jul 18, 2024
• Gossamer Bio Reports on Shareholder Vote Matters — 8-K · Jun 10, 2024
• Gossamer Bio Faces Delisting Concerns — 8-K · May 24, 2024
• Gossamer Bio, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 7, 2024
• Gossamer Bio Terminates J&J Agreement, Reports Equity Sales — 8-K · May 6, 2024
• Gossamer Bio, Inc. Files Definitive Proxy Statement (DEF 14A) — DEF 14A · Apr 24, 2024
• Gossamer Bio Appoints New CEO, Dr. Gujrathi Takes Helm — 8-K · Mar 12, 2024
• Gossamer Bio, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 5, 2024
• Roivant to Acquire Gossamer Bio for $1.7B — 8-K · Mar 4, 2024
• Gossamer Bio, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Gossamer Bio, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• ARCH Venture Fund IX Exits Gossamer Bio Position — SC 13G/A · Feb 9, 2024
• FMR LLC & Abigail Johnson Disclose 5.44% Stake in Gossamer Bio — SC 13G · Feb 9, 2024
• Millennium Management Amends Gossamer Bio Stake — SC 13G/A · Jan 11, 2024
• Artal Group & Invus Disclose Significant Stake in Gossamer Bio — SC 13G · Jan 11, 2024